Skip to content
naulon

Not checkedNot checked for notices yet.

Influence of sex as an intrinsic biological variable in a primary cell model of HIV latency

A.B. Macedo, L.J. Martins, A.M. Spivak and 3 more

Journal of Virus Eradication · 2017

doi:10.1016/s2055-6640(20)30597-5 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Background: Persistent HIV infection in the CNS despite lifeprolonging antiretroviral (ARV) treatment increases activation of macrophages (MΦ), microglia, and surrounding astrocytes/neurons, conferring HIV-induced inflammation resulting in HIV-associated neurocognitive disorders (HAND).We developed a novel primary human stem cell-derived microglia cell system to quantify effects HIV-induced neuroinflammation and persistence.Additionally we developed a high throughput FACS based readout to evaluate the potency of ARV and quantify brain pathology in a murine model of HAND.Methods: Stem cell or monocyte-derived microglia were differentiated with GM-CSF, IL-34, dorsimorphin, fibrinogen-growth-factor-2, and neuro-broth medium.Cells were confirmed pure (FACS) by antibody staining with: CD11b+/CD3-/CD14-/CD3-/CD14-/CD45+/ CD11b+/CX3CR1+/CD80/86-/IBA-1+/CD39(lo+).MΦ were differentiated with GM-CSF.Cells were infected with HIV-1BaL for 4 hr with various concentrations of anti-inflammatory Jak 1/2 inhibitor baricitinib, AZT or Darunavir followed by culture in drug-containing medium for 14 days prior to viral quantification (RT assay).HLA-DR/ CD163 were quantified (flow cytometry).Human MΦ were infected with HIVADA and used in our established HIV-HAND model.Day 14 days post infection, mice were sacrificed; brains were removed and single-cell suspensions were stained (CD45, MAP2, GFAP, MHCII, human-CD163, or p24; flow cytometry).Results: In microglia, all antiviral agents except AZT demonstrated significantly (p < 0.01) greater potency compared to MΦ. Baricitinib significantly reduced (p < 0.01) HIV-induced activation of microglia and MΦ (CD163/HLA-DR).In mice, GFAP/CD45/MHCII (astrogliosis and macrophage infiltrate markers) increased significantly (p < 0.01) in HIV-infected brains versus uninfected controls.MAP2+ (neuronal cells) were significantly (p < 0.05) reduced in HIV-infected brains versus uninfected brains.Conclusions: We demonstrated for the first time that primary stem cell-derived microglia can be infected with HIV, and that this system can be used to quantify effect of antiviral agents on HIV replication and HIV-induced inflammatory events driving HAND.These data represent an innovative, physiolgically relevant primary cell system that can be used in tandem with our murine HAND model to evalulate agents targeting reservoirs and viral persistence in the CNS.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.